ArticleWorld journal of gastroenterology2025

CRAFITY score and nomogram predict the clinical efficacy of lenvatinib combined with immune checkpoint inhibitors in hepatocellular carcinoma.

Xue Yin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.